Immunovant (IMVT) Enterprise Value (2018 - 2026)
Immunovant (IMVT) reported Enterprise Value of -$902.1 million for Q1 2026, down 26.35% on a YoY basis from -$1.2 billion in Q1 2025, and up 9.29% quarter-over-quarter from -$994.5 million in Q4 2025.
Immunovant (IMVT) Enterprise Value (2018 - 2026) Analysis & Trends
Immunovant has reported Enterprise Value for 9 years, with the latest figure at -$902.1 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 26.35% year-over-year to -$902.1 million; the trailing twelve-month figure through Mar 2026 stood at -$902.1 million (down 26.35% YoY), and the FY2026 full-year result was -$902.1 million, down 26.35% from the prior year.
- Enterprise Value for Q1 2026 stood at -$902.1 million, up from -$994.5 million in the prior quarter.
- The five-year high for Enterprise Value was -$269.9 million in Q3 2023, with the low at -$994.5 million in Q4 2025.
- Historically, Enterprise Value has averaged -$541.2 million across 5 years, with a median of -$493.8 million in 2022.
- Annual changes were most pronounced in 2024 — Enterprise Value jumped 45.77% — and 2025, when it sank 165.42%.
- Immunovant's Enterprise Value stood at -$432.6 million in 2022, then plunged by 59.71% to -$690.9 million in 2023, then jumped by 45.77% to -$374.7 million in 2024, then slumped by 165.42% to -$994.5 million in 2025, then climbed by 9.29% to -$902.1 million in 2026.
- The last three Enterprise Value figures came in at -$902.1 million (Q1 2026), -$994.5 million (Q4 2025), and -$521.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -584.73 Mn |
| 10 | Immunovant | 5.71 Bn | 5.71 Bn | - | -902.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -902.11 Mn |
| Dec 31, 2025 | -994.53 Mn |
| Sep 30, 2025 | -521.87 Mn |
| Jun 30, 2025 | -598.90 Mn |
| Mar 31, 2025 | -713.97 Mn |
| Dec 31, 2024 | -374.70 Mn |
| Sep 30, 2024 | -472.94 Mn |
| Jun 30, 2024 | -560.00 Mn |
| Mar 31, 2024 | -635.37 Mn |
| Dec 31, 2023 | -690.90 Mn |
| Sep 30, 2023 | -269.93 Mn |
| Jun 30, 2023 | -329.96 Mn |
| Mar 31, 2023 | -376.53 Mn |
| Dec 31, 2022 | -432.61 Mn |
| Sep 30, 2022 | -405.80 Mn |
| Jun 30, 2022 | -427.21 Mn |
| Mar 31, 2022 | -493.82 Mn |
| Dec 31, 2021 | -527.00 Mn |
| Sep 30, 2021 | -558.95 Mn |
| Jun 30, 2021 | -379.01 Mn |